Jesse St. Jean

Ph.D. Candidate & Research Scientist

Jesse is currently enrolled as a Ph.D. student at the University of Waterloo, within the School of Pharmacy. Jesse completed his undergraduate degree in Behavioural Neuroscience at Laurentian University, a program that highlighted the molecular mechanisms of neurological disorders. Under the supervision of Dr. Slavcev, Jesse has completed an internship with Mediphage Bioceuticals and Illumina examining the transcriptomic profile of a cellular model of Alzheimer's disease. His current project evaluates bacteriophage M13-based gene delivery in the targeted treatment of Alzheimer’s disease.

Education

B.Sc. Honours in Behavioural Neuroscience, Laurentian University (2017)

Contact

jesse.st.jean@theraphage.bio

PUBLICATIONS:

Jean, J.S., Slavcev, R.A., & Rao, P.P. (2023). The effects of amyloid beta aggregation on neuronal transcription. IBRO neuroscience reports, 14, 375-379 .
Huh, H., Wong, S., St Jean, J., & Slavcev, R.A. (2019). Bacteriophage interactions with mammalian tissue: Therapeutic applications. Advanced drug delivery reviews.

BOOK CONTRIBUTIONS:

Slavcev, R.A., Sum, C.H., St Jean, J., Huh, H., & Nafissi, N. (2018). Specific Systems for Evaluation. Experientia supplementum, 110, 99-123

Presentations:

St. Jean J. The Evaluation of Bacteriophage M13-Based Gene Delivery in the Targeted Treatment of Alzheimer’s Disease. Presented at: University of Waterloo Graduate Studies Seminar Series. 2022 Jan 20. Waterloo, ON
St. Jean J. The effects of amyloid beta aggregation on neuronal transcription. Presented at: University of Waterloo Pharmacy Research Day. 2021 May 5; Waterloo, ON.
St. Jean J. Using transcriptomics to guide gene therapy in Alzheimer's disease. Presented at: CBB-Symposium: Smart Aging and Rehabilitation Technologies. 2019, Jun 19; Waterloo, ON.
St. Jean J, Slavcev, R. Analyzing the transcriptomics of Alzheimer’s disease and the effects of treatment with bacteriophage M13. Poster presented at: BioTEC 2018. 2018